We are live on
!
Find out more
BCPEMI
Bain Capital Public Equity Management II Portfolio holdings
AUM
$62.1M
1-Year Est. Return
25.46%
This Fund
S&P 500
This Quarter
Est. Return
+1.8%
1 Year Est. Return
+25.46%
3 Year Est. Return
+200.73%
5 Year Est. Return
+313.45%
10 Year Est. Return
–
AUM
$3.13B
AUM Growth
+$126M
(+4.2%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
4.74%
Top 10 Holdings %
Top 10 Hldgs %
49.61%
Holding
60
New
15
Increased
10
Reduced
18
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Check Point Software Technologies
CHKP
|
+$104M |
| 2 |
Intercontinental Exchange
ICE
|
+$89.1M |
| 3 |
Allstate
ALL
|
+$83.6M |
| 4 |
Oracle
ORCL
|
+$77.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$62.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameriprise Financial
AMP
|
+$138M |
| 2 |
ICICI Bank
IBN
|
+$106M |
| 3 |
Salesforce
CRM
|
+$103M |
| 4 |
Raymond James Financial
RJF
|
+$85.5M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 22.28% |
| 2 | Technology | 20.58% |
| 3 | Financials | 19.81% |
| 4 | Communication Services | 7.48% |
| 5 | Healthcare | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
National Vision
EYE
$1.6B
| $54.5M | 1.74% |
1,249,952
-606,802
| -33% | -$24.6M |
|
27
Amdocs
DOX
$6.01B
| $54.1M | 1.73% |
+657,547
| New | +$51.5M |
|
28
Sanofi
SNY
$104B
| $50.5M | 1.62% |
984,348
+572,780
| +139% | +$29.6M |
|
29
PUT
iShares Russell 2000 ETF
IWM
$81.9B
| $43.7M | 1.4% |
+213,000
| New | +$43.4M |
|
30
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
| $43.2M | 1.38% |
+1,160,000
| New | +$40.2M |
|
31
Global E Online
GLBE
$7.1B
| $37.2M | 1.19% |
1,101,838
+297,060
| +37% | +$11.2M |
|
32
Lightspeed Commerce
LSPD
$1.32B
| $27.8M | 0.89% |
+913,934
| New | +$27.2M |
|
33
New York Times
NYT
$10.4B
| $26.3M | 0.84% |
573,428
-725,631
| -56% | -$31.4M |
|
34
Five Below
FIVE
$12.9B
| $17.1M | 0.55% |
108,160
-217,247
| -67% | -$36.2M |
|
35
Cytokinetics
CYTK
$10.6B
| $15.2M | 0.49% |
411,855
+70,583
| +21% | +$2.51M |
|
36
PUT
DoorDash
DASH
$92.6B
| $14.1M | 0.45% |
+120,000
| New | +$13M |
|
37
Immunocore
IMCR
$1.75B
| $9.5M | 0.3% |
317,676
-394,275
| -55% | -$9.95M |
|
38
BioCryst Pharmaceuticals
BCRX
$2.6B
| $8.46M | 0.27% |
520,199
-907,178
| -64% | -$14.6M |
|
39
PUT
Teladoc Health
TDOC
$1.2B
| $6.78M | 0.22% |
94,000
-163,700
| -64% | -$11.8M |
|
40
Arcus Biosciences
RCUS
$3.68B
| $5.92M | 0.19% |
187,572
-235,193
| -56% | -$7.88M |
|
41
PUT
Wayfair
W
$14.4B
| $4.13M | 0.13% |
+37,300
| New | +$5.25M |
|
42
Hyperfine
HYPR
$95.6M
| $3.27M | 0.1% |
924,126
-645,560
| -41% | -$2.67M |
|
|
AFMD
43
DELISTED
Affimed
AFMD
| $2.54M | 0.08% |
58,234
-179,076
| -75% | -$7.78M |
|
|
44
Ameriprise Financial
AMP
$49.5B
| – | – |
-457,380
| Closed | -$138M |
|
45
PUT
ARK Genomic Revolution ETF
ARKG
$1.78B
| – | – |
-215,000
| Closed | -$13.2M |
|
|
CCC
46
CCC Intelligent Solutions
CCC
$3.95B
| – | – |
-2,187,650
| Closed | -$24.9M |
|
47
Curis
CRIS
$4.7M
| – | – |
-1,055
| Closed | -$2.01M |
|
|
48
Salesforce
CRM
$158B
| – | – |
-404,870
| Closed | -$103M |
|
49
PUT
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| – | – |
-1,119,700
| Closed | -$54.7M |
|
|
50
ICICI Bank
IBN
$107B
| – | – |
-5,363,944
| Closed | -$106M |
|
Similar funds
RRCP
PCM
KWM
AC
RWA
VI
QEI
BBW
Bain Capital Public Equity Management II's Q1 2022 Portfolio in Review
As of Q1 2022, Bain Capital Public Equity Management II held 60 positions worth $3.13B, up 4.2% from $3B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Bain Capital Public Equity Management II deployed $148M of net new capital in Q1 2022, opening 15 new positions and adding to 10 existing holdings. Its largest new stake was Check Point Software Technologies: 792,962 shares worth $110M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 29% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Signature Bank, an estimated $72M trimmed.
- Bain Capital Public Equity Management II's largest Q1 2022 buy was Check Point Software Technologies: 792,962 shares worth $110M.
- Bain Capital Public Equity Management II added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022, an estimated $62.3M increase.
- Bain Capital Public Equity Management II's biggest Q1 2022 reduction was Signature Bank, cutting an estimated $72M.
- Bain Capital Public Equity Management II fully exited Ameriprise Financial in Q1 2022, selling an estimated $138M.
- Bain Capital Public Equity Management II's ten largest holdings make up 50% of its $3.13B portfolio in Q1 2022.
- Bain Capital Public Equity Management II opened 15 new positions and closed 17 in Q1 2022.
- Bain Capital Public Equity Management II's portfolio value rose 4.2% quarter-over-quarter to $3.13B.
Based on Bain Capital Public Equity Management II's 13F filing for Q1 2022, filed 16 May 2022.